BMRN vs SLDE · P/E 40, rev $1.76B vs rev $1.16B
Biomarin Pharmaceutical Inc (BMRN) versus Slide Insurance Holdings, Inc. Common Stock (SLDE) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Slide Insurance Holdings, Inc. Common Stock (SLDE) is a insurance - property & casualty company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported SLDE revenue for 2025-12-31 was $1.16B. Net income was $444.0M. Revenue was up 36.5% from 2024-12-31 to 2025-12-31. SLDE currently screens at market cap $0.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. SLDE currently screens at market cap $0.
Not investment advice. Open the BMRN and SLDE stock pages for the full models.
Not investment advice.